How to Cite
Abstract
The increase in the global prevalence of Human Immunodeficiency Virus, likewise the increase in cardiovascular manifestations associated with this disease are relevant issues in current medicine. The Human Immunodeficiency Virus changes in its epidemiology, transforming from an acute disease to a chronic disease. Thanks in part to the new generation of antiretrovirals, which produce fewer side effects, and also show an improvement in adherence to treatment that results in a life expectancy close to the general population. The control and treatment of cardiovascular risk factors are fundamental in therapeutic treatment. Patients with optimal treatment do not have a worse prognosis than the population without infection, but have an increase in the rate of recurrence of cardiovascular complications.Keywords
References
Feinstein M, Nance R, Delaney J, Heckbert S, Budoff M, Drozd D et al. Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS).BMC Medicine [Internet].2019[citado 26/1/2020]; 17(1). https://doi.org/10.1186/s12916-019-1385-7
-Butler J, Kalogeropoulos AP, Anstrom KJ, Hsue PY, Kim RJ, Scherzer R, et al. Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) Study. Journal of Cardiac Failure [Internet]. 2018 [citado: 27/12/2019]; 24(4):255-265. https://doi.org/10.1016/j.cardfail.2018.02.001
Kaplan RC, Hanna DB, Kizer JR. Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults. Current HIV/AIDS Reports [Internet]. 2016 [citado: 27/12/2019; 13(1):44-52. https://doi.org/10.1007/s11904-016-0301-4
Lambert CT, Sandesara PB, Hirsh B, Shaw LJ, Lewis W, Quyyumi AA, et al. HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review. HIV Medicine [Internet]. 2016 [citado: 27/12/2019]; 17(6):411-424. https://doi.org/10.1111/hiv.12346
Wandeler G, Johnson LF, Egger M. Trends in life expectancy of HIV-positive adults on anti-retroviral therapy across the globe: comparisons with general population. Current Opinion in HIV and AIDS [Internet]. 2016 [citado: 27/12/2019]; 11(5):492-500. https://doi.org/10.1097/COH.0000000000000298
Boccara F, Cohen A. VIH y cardiopatía:¿qué deben saber los cardiólogos? Revista Española de Cardiología[Internet]. 2016 [citado: 27/12/2019]; 69(12):1126-1130. https://doi.org/10.1016/j.recesp.2016.05.037
Vicente Muller E, Agostinho Gimeno S. Risk factors for cardiovascular disease in HIV/AIDS patients treated with highly active antiretroviral therapy (HAART) in the central-southern region of the state of Paraná - Brazil. Ciência & Saúde Coletiva [Internet]. 2019 [citado: 27/12/2019]; 24(5):1903-1914. https://doi.org/10.1590/1413-81232018245.16682017
Hawkins K, Brown T, Margolick J, Erlandson K. Geriatric syndromes. AIDS. [Internet] 2017[citado 26/1/2020]; 31:S137-S146. https://doi.org/10.1097/QAD.0000000000001444
Saiz LC, Gorricho J, Garjón J, Celaya MC, Muruzábal L, Malón MDM, et al. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease (Review). Cochrane Data-base of Systematic Reviews [Internet]. 2017 [citado: 27/12/2019]; 10: CD010315. https://doi.org/10.1002/14651858.CD010315.pub3
Chastain DB, Stover KR, Riche DM. Evidence-based review of statin use in patients with HIV on antiretroviral therapy. Journal of Clinical & Translational Endocrinology [Internet]. 2017 [citado: 27/12/2019]; 8:6-14. https://doi.org/10.1016/j.jcte.2017.01.004
Ahmed M, Woodward C, Mital D. Metabolic clinic for individuals with HIV/AIDS. Cardiovascular Endocrinology [Internet].2017[citado: 27/1/2020]; 6(3):109-112. https://doi.org/10.1097/XCE.0000000000000128
Freiberg MS, Chang CCH, Skanderson M, Patterson OV, DuVall SL, Brandt CA, et al. Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era. JAMA Cardiology [Internet].2017 [citado:27/12/2019]; 2(5):536-546.https://doi.org/10.1001/jamacardio.2017.0264
Hsue PY, Waters DD. Heart failure in persons living with HIV infection. Current Opinion in HIV and AIDS [Internet].2017 [citado: 27/12/2019];12(6):534-539. https://doi.org/10.1097/COH.0000000000000409
Alikhani A, Morin H, Matte S, Alikhani P, Tremblay C, Durand M. Association between li-podystrophy and length of exposure to ARTs in adult HIV-1 infected patients in Montreal. BMC Infectious Diseases [Internet]. 2019 [citado: 27/12/2019];19(1). https://doi.org/10.1186/s12879-019-4446-9
Raposeiras-Roubín S, Triant V. Cardiopatía isquémica en el VIH: profundizando en el conocimiento del riesgo cardiovascular. Rev Esp Cardiol [Internet]. 2016 [citado: 27/12/2019]; 69(12):1204-1213. https://doi.org/10.1016/j.recesp.2016.08.035
Valderrama Beltrán SL Gualtero SM, Quiroga C, Garzón JR, Lowenstein de Mendivelson E, Tamara JR, et al. Evaluación y manejo del riesgo cardiovascular en infección por VIH. Consenso de expertos ACIN. Infectio [Internet]. 2018 [citado: 27/12/2019]; 23(S1):73-91. https://doi.org/10.22354/in.v23i1.762
De Wit S, Battegay M, D'Arminio Monforte A, Lundgren J, Oprea C, Antinori A, et al. European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16-17 November 2016: a summary. HIV Medicine [Internet].2017 [citado: 27/12/2019]; 19(2):77-80. https://doi.org/10.1111/hiv.12559
Documento de consenso de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos con infección por el virus de la inmunodeficiencia humana (Actualización enero 2015). Enfermedades Infecciosas y Microbiología Clínica [Internet]. 2015 [citado: 27/12/2019];33(8):543.e1-543.e43. https://doi.org/10.1016/j.eimc.2015.03.016
Regan S, Meigs J, Grinspoon S, Triant V. Determinants of Smoking and Quitting in HIV-Infected Individuals. PLOS ONE [Internet].2016 [citado 26/1/2020];11(4):e0153103. https://doi.org/10.1371/journal.pone.0153103